Explore a selection of our essential drug information below, or:
Identification
- Summary
Dolichovespula arenaria venom protein is a venom protein produced by the common aerial yellowjacket wasp used in allergy testing.
- Generic Name
- Dolichovespula arenaria venom protein
- DrugBank Accession Number
- DB10957
- Background
Dolichovespula arenaria venom protein is an extract of Dolichovespula arenaria venom. Dolichovespula arenaria venom protein is used in allergenic testing.
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Allergenics
Allergen Extract - Synonyms
- Dolichovespula arenaria venom protein extract
- yellow hornet venom protein
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Hymenoptera Venom Products-yellow Hornet Venom Protein (550 Mcg) Powder, for solution 550 mcg / vial Subcutaneous Jubilant Hollisterstier Llc 1997-12-16 Not applicable Canada 
Pharmalgen Yellow Hornet Venom Powder, for solution 1.1 mg / vial Intradermal; Subcutaneous Alk Abelló A/S 1996-09-16 2023-02-07 Canada Pharmalgen Yellow Hornet Venom Protein Powder, for solution 120 mcg / vial Intradermal; Subcutaneous Alk Abelló A/S 1992-12-31 2023-02-07 Canada Venomil Inj 100mcg/ml(yellow Hornet) Liquid 100 mcg / mL Subcutaneous Hollister Stier, Unit Pharm, Division Of Miles Canada Inc. 1983-12-31 1998-09-25 Canada Venomil Inj 10mcg/ml Yellow Hornet Liquid 10 mcg / mL Subcutaneous Hollister Stier, Unit Pharm, Division Of Miles Canada Inc. 1983-12-31 1998-09-25 Canada - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Hymenoptera Venom Diagnostic Dolichovespula arenaria venom protein (120 ug/1) + Apis mellifera venom (120 ug/1) + Dolichovespula maculata venom protein (120 ug/1) + Polistes fuscatus venom protein (120 ug/1) + Vespula maculifrons venom protein (120 ug/1) Kit Subcutaneous ALK-Abello A S 1992-11-20 2010-04-09 US 
Hymenoptera Venom Product-mixed Vespid Venom Protein (1650 Mcg) Dolichovespula arenaria venom protein (550 mcg / vial) + Dolichovespula maculata venom protein (550 mcg / vial) + Vespula vulgaris venom protein (550 mcg / vial) Powder, for solution Subcutaneous Jubilant Hollisterstier Llc 1997-12-16 Not applicable Canada Mixed Vespid Hymenoptera Venom Multidose Dolichovespula arenaria venom protein (100 ug/1mL) + Dolichovespula maculata venom protein (100 ug/1mL) + Vespula germanica venom protein (20 ug/1mL) + Vespula maculifrons venom protein (20 ug/1mL) + Vespula pensylvanica venom protein (20 ug/1mL) + Vespula squamosa venom protein (20 ug/1mL) + Vespula vulgaris venom protein (20 ug/1mL) Injection, powder, lyophilized, for solution Subcutaneous Jubilant Hollisterstier Llc 1980-12-11 Not applicable US Mixed Vespid Hymenoptera Venom Multidose Dolichovespula arenaria venom protein (100 ug/1mL) + Dolichovespula maculata venom protein (100 ug/1mL) + Vespula germanica venom protein (20 ug/1mL) + Vespula maculifrons venom protein (20 ug/1mL) + Vespula pensylvanica venom protein (20 ug/1mL) + Vespula squamosa venom protein (20 ug/1mL) + Vespula vulgaris venom protein (20 ug/1mL) Injection, powder, lyophilized, for solution Subcutaneous Jubilant Hollisterstier Llc 1995-04-11 Not applicable US Mixed Vespid Hymenoptera Venom Venomil Maintenance Dolichovespula arenaria venom protein (100 ug/1mL) + Dolichovespula maculata venom protein (100 ug/1mL) + Vespula germanica venom protein (20 ug/1mL) + Vespula maculifrons venom protein (20 ug/1mL) + Vespula pensylvanica venom protein (20 ug/1mL) + Vespula squamosa venom protein (20 ug/1mL) + Vespula vulgaris venom protein (20 ug/1mL) Kit Subcutaneous Jubilant Hollisterstier Llc 1982-02-22 Not applicable US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 7PI26E943G
- CAS number
- Not Available
References
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Kit Subcutaneous Powder, for solution Subcutaneous 550 mcg / vial Injection, powder, lyophilized, for solution Subcutaneous Powder, for solution Subcutaneous Powder, for solution Intradermal; Subcutaneous Powder, for solution Intradermal; Subcutaneous 1.1 mg / vial Powder, for solution Intradermal; Subcutaneous 120 mcg / vial Liquid Subcutaneous 100 mcg / mL Liquid Subcutaneous 10 mcg / mL Liquid Subcutaneous Kit; powder, for solution Intradermal Injection, powder, lyophilized, for solution Percutaneous; Subcutaneous 100 ug/1mL Kit Intradermal; Percutaneous 100 ug/1mL Kit Subcutaneous 100 ug/1mL Injection, powder, lyophilized, for solution Subcutaneous 100 ug/1mL Powder, for solution Intradermal; Subcutaneous 500 mcg / vial - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at December 01, 2015 20:04 / Updated at September 15, 2024 21:55